This paper proposes a new regulatory incentive mechanism to induce efficient investment in electricity transmission networks. Energy Economics: http://bit.ly/2PeCEpu
The author reviews some of the regulatory, financial and planning challenges for electricity transmission. Economics of Energy & Environmental Policy symposium: http://bit.ly/2KMRUvf.
The authors conducted mobile phone surveys on energy supply, demand and quality in 12 sub-Saharan African countries, finding that current grid and off-grid electricity supply is inadequate to meet consumers' demands.
This paper assesses the current operational conditions of the Mexican residential electricity sector and examines the potential effects that the massive adoption of distributed photovoltaic power generation (DPV) systems would have on household expenditure and welfare, subsidy reduction, pollution and water resource usage.
Pedro Hancevic, Hector Nuñez, Juan RosellónSeptember 4, 2017
The authors calculate nodal prices for Mexico's power system and analyze how the allocation of financial transmission rights can be used to mitigate resulting effects on electricity distribution. The Energy Journal: http://bit.ly/2UKrw9R
Friedrich Kunz, Juan Rosellón, Claudia KemfertJune 17, 2017
Mexico should consider expanding its 2014 energy reform legislation by further designing policies that seek to promote enhanced generation output and capacity, which could expand economic growth, the authors write in this study: http://bit.ly/2DpaDai
Mexico's electricity market has engaged in a deep reform process after decades of a state-owned, vertically integrated, noncompetitive closed industry. Using different modeling strategies, the authors of this paper analyze electricity transmission planning under the new industrial and institutional structure, which is characterized by a nodal pricing system and an independent system operator (ISO).
The winner’s curse — overestimating the value of an asset and therefore overpaying — is often associated with acquisitions of publicly-traded firms but not with private acquisitions. Using an event study methodology for over 22,000 private acquisitions of U.S. firms between 1985 and 2015, the authors examine a possible winner’s curse for such acquisitions, testing variables to determine what characteristics make a private company more likely to overestimate the asset's value.
Every patient with cancer or another life-threatening disease wants the most effective treatment, but drug prices have become staggering. What determines the escalating prices of cancer drugs?
Donald Light, Hagop M. KantarjianSeptember 3, 2013